Dong Sung Bio Pharm.Co.,Ltd. Statistics

Total Valuation

Dong Sung Bio Pharm.Co.,Ltd. has a market cap or net worth of KRW 102.33 billion.

Market Cap	102.33B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Dong Sung Bio Pharm.Co.,Ltd. has 22.87 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	22.87M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2.99%
Owned by Insiders (%)	24.27%
Owned by Institutions (%)	0.41%
Float	17.32M

Valuation Ratios

The trailing PE ratio is 46.45.

PE Ratio	46.45
Forward PE	n/a
PS Ratio	1.01
PB Ratio	1.31
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.58.

Current Ratio	1.47
Quick Ratio	1.18
Debt / Equity	0.58
Debt / EBITDA	7.57
Debt / FCF	-11.55
Interest Coverage	1.55

Financial Efficiency

Return on equity (ROE) is 2.85% and return on invested capital (ROIC) is 2.07%.

Return on Equity (ROE)	2.85%
Return on Assets (ROA)	1.54%
Return on Capital (ROIC)	2.07%
Revenue Per Employee	270.49M
Profits Per Employee	5.87M
Employee Count	290
Asset Turnover	0.62
Inventory Turnover	3.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.70% in the last 52 weeks. The beta is 0.50, so Dong Sung Bio Pharm.Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-30.70%
50-Day Moving Average	4,521.60
200-Day Moving Average	4,950.70
Relative Strength Index (RSI)	45.15
Average Volume (20 Days)	62,005

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dong Sung Bio Pharm.Co.,Ltd. had revenue of KRW 78.44 billion and earned 1.70 billion in profits. Earnings per share was 96.34.

Revenue	78.44B
Gross Profit	45.21B
Operating Income	3.10B
Pretax Income	1.75B
Net Income	1.70B
EBITDA	4.61B
EBIT	3.10B
Earnings Per Share (EPS)	96.34

Full Income Statement

Balance Sheet

The company has 14.25 billion in cash and 34.93 billion in debt, giving a net cash position of -20.68 billion or -904.60 per share.

Cash & Cash Equivalents	14.25B
Total Debt	34.93B
Net Cash	-20.68B
Net Cash Per Share	-904.60
Equity (Book Value)	60.20B
Book Value Per Share	3,409.29
Working Capital	24.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.64 billion and capital expenditures -380.70 million, giving a free cash flow of -3.02 billion.

Operating Cash Flow	-2.64B
Capital Expenditures	-380.70M
Free Cash Flow	-3.02B
FCF Per Share	-132.25

Full Cash Flow Statement

Margins

Gross margin is 57.64%, with operating and profit margins of 3.96% and 2.17%.

Gross Margin	57.64%
Operating Margin	3.96%
Pretax Margin	2.23%
Profit Margin	2.17%
EBITDA Margin	5.88%
EBIT Margin	3.96%
FCF Margin	-3.86%

Dividends & Yields

Dong Sung Bio Pharm.Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	31.14%
Buyback Yield	2.59%
Shareholder Yield	2.59%
Earnings Yield	2.15%
FCF Yield	-2.96%

Stock Splits

The last stock split was on December 18, 2008. It was a forward split with a ratio of 5.

Last Split Date	Dec 18, 2008
Split Type	Forward
Split Ratio	5

Scores

Dong Sung Bio Pharm.Co.,Ltd. has an Altman Z-Score of 1.51. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	n/a